Purification of DNA and/or RNA: for DNA and RNA from cell-free media (serum, plasma, body fluids and the supernatant from viral infected cell cultures)
The Bio-Shield Surface Ag 2019-nCov is an ELISA test for the measurement of SARS-CoV-2 Nucleocapsid Protein (NP) in swabs of common surfaces. The test is intended for environmental swabbing of larger facilities & spaces and is adequate for up to 48 sample definitions at a time.
The Rapid Surface Ag 2019-nCov is a rapid test for the detection of SARS-CoV-2 Nucleocapsid Protein Antigen (NP) in swabs of common surfaces, such as metal, plastic, glass, paper, and stainless steel. It is the first product for COVID-19 surface testing to utilize this innovative methodology. The Rapid Surface Ag 2019-nCov is a valuable tool for several sectors enabling the companies to monitor and mitigate the spread of COVID-19 in their facilities and maintain a safe operating environment.
Detection of RNA of SARS-CoV strains including SARS-CoV-2 and SARS-like CoV without discriminating between strains. Detection of the virus is responsible for the disease COVID-19 (corona virus disease 2019) and also detection of the new SARS-CoV-2 variant from the UK B1.1.7 (VOC-202012/01), the Delta variant and the variant from South Africa B.1.1.529.
Rapid Test Ag 2019-nCov is a lateral flow test with high sensitivity for the detection of SARS-CoV-2 antigen (nucleocapsid protein) in nasal or nasopharyngeal swab specimens. It helps to rapidly identify infected individuals, enabling prompt clinical decisions and preventing a potential virus outbreak. The test does not require any special instrument and can be used in all types of premises.
0.8456164747476578
Cookies help us deliver our services. By using our services, you agree to our use of cookies.